Building Clinical Confidence: Evidence-based Care for People Living with MS: Module 2. Emerging disease-modifying therapies for relapsing MS

Accreditation
In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
Physicians
The CMSC designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
The CMSC designates this activity for a maximum of 1.00 NCPD credit (1.00 in the area of pharmacology).

Pharmacists
This knowledge-based activity, UAN: JA4008165-9999-23-002-H01-P, qualifies for 1.00 contact hours (0.10 CEUs) of continuing pharmacy education credit.